1-3 of 3
nucleoside reverse transcriptase inhibitors
Close
Sort by
Journal Articles

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Hasmukh Jain, Manju Sengar, Hari Menon, MD DM, Tanuja Shet, MD, Epari Sridhar, MD Pathology, Bhausaheb Bagal, MD DM, Siddhartha Laskar, MD Radiation Oncology, Sumeet Gujral, MD, Navin Khattry, MD DM, Archi Agarwal, Nuclear MD cine, Deepa SUSAN Philip, MD
Journal: Blood
Blood (2016) 128 (22): 4213.
https://doi.org/10.1182/blood.V128.22.4213.4213
Published: 2016
Journal Articles

Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Associated Burkitt’s Lymphoma (BL)

Silvia Montoto, MD, Jamie Wilson, Kate Shaw, Maureen Heath, Andy Wilson, Chloe Orkin, Christopher McNamara, Margaret Johnson, Mark Bower, Kate Cwynarski
Journal: Blood
Blood (2008) 112 (11): 3612.
https://doi.org/10.1182/blood.V112.11.3612.3612
Published: 2008
Journal Articles

Deficiency of 2,3-Dimethoxy-5-Methyl-6-Decaprenyl-1,4-Benzoquinone (Mitoquinone) and Hyperlactic Acidosis in Human Immunodeficiency Virus (HIV) Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Based HAART and Chemoradiation.

Eugene McPherson, MD, PhD, E. Mejia, MD, E. Hazel, MD, P. Tassy, MD
Journal: Blood
Blood (2005) 106 (11): 3899.
https://doi.org/10.1182/blood.V106.11.3899.3899
Published: 2005